As any healthcare founder knows, it can be difficult to get into a room with the executives making purchase decisions for payors and providers—so we’re bringing the executives to you.
This episode features interviews with payor and provider leaders about what they’re seeing and how they’re thinking about AI. Guided by Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, you'll hear from the executives about how they're utilizing AI, the KPIs they use to gauge effectiveness, and what they consider a good partnership.
Julie and Jay also authored an in-depth guide to commercializing AI in healthcare based on these interviews, available here. All of our go-to-market playbooks are available on our Digital Health Builders page.
The Science and Supply of GLP-1s with Carolyn Jasik
The Intersection of Biotech x High Tech with Vineeta Agarwala
AI in Pharmaceutical R&D with Kim Branson
Unleashing CAR T with Carl June
Longevity as a Health Asset with Tom Hale
The Power of Drug Discovery with Philip Tagari
AI-Enabled Continuity of Care with Ed and Todd Park
Grand Challenges in Healthcare AI with Vijay Pande and Julie Yoo
Adapting Biopharma to AI with Greg Meyers
Biotech Revolution with Software Engineering Daily
Dark Genome Hunting with Rosana Kapeller and Marty Taylor
DNA as Data Storage with Vijay Pande
The Most Interesting Healthcare Companies You've Never Heard Of with Julie Klapstein
CRISPR by Design with Benjamin Oakes
Metrics for a Complex Machine with Josh Clemente
Transitioning From Gymnast to Investor with Aly Raisman
Finding PMF in Healthcare (After Tasting it Elsewhere) with Eren Bali and Max Cohen
IRA, AI Regulation, and the Future with Joe Grogan
Drag & Drop Genome Editing
Create your
podcast in
minutes
It is Free